# Immune-Onc Therapeutics funding: rounds and investors

> Immune-Onc Therapeutics has raised $25M across 1 round since 2023. Investors include Northern Light Venture Capital and Vivo Capital.

Source: https://millionrounds.com/company/immune-onc-therapeutics (Millionrounds; every figure on the page links to its filing or article)

United States · [Series B startup](https://millionrounds.com/companies)

# Who invested in *Immune-Onc Therapeutics*

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summary Updated 26 Oct 2026

**$25M** raised across 1 round since 2023, from 1 source

- **Latest round:** Series B, $25M Jan 2023
- **Investors:** 2

See who backed them

## The rounds

- **Jan 2023** Series B **$25M** [Northern Light Venture Capital](https://millionrounds.com/fund/nlvc) [Vivo Capital](https://millionrounds.com/fund/vivo-capital) Source recorded

## Founders and team

From the SEC filings it signed: 2 on the team.

- **Guo-Liang Yu** Board of Directors
- **Xiaoling Charlene Liao** Executive Officer, Director i

On the board, as filed i *Liqun Luo*

## Everyone who backed them

[Northern Light Venture Capital](https://millionrounds.com/fund/nlvc) VC firm **1** round

[Vivo Capital](https://millionrounds.com/fund/vivo-capital) Private equity **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=immune-onc-therapeutics).

## Quick answers about Immune-Onc Therapeutics

### Who invested in Immune-Onc Therapeutics?

Immune-Onc Therapeutics's investors include Northern Light Venture Capital and Vivo Capital.

### How much has Immune-Onc Therapeutics raised?

Immune-Onc Therapeutics has raised $25M across 1 round since 2023.

### When did Immune-Onc Therapeutics last raise?

Immune-Onc Therapeutics's most recent round was a Series B of $25M in Jan 2023.

### What was Immune-Onc Therapeutics's biggest round?

Its most recent round, $25M in Jan 2023, is also its largest on record.

### Who backed Immune-Onc Therapeutics first?

Immune-Onc Therapeutics's first round on record, in Jan 2023, was backed by Northern Light Venture Capital and Vivo Capital.

### What stage is Immune-Onc Therapeutics at?

Immune-Onc Therapeutics's latest named round is a Series B, in Jan 2023.

### Where is Immune-Onc Therapeutics based?

Immune-Onc Therapeutics is based in the United States.

## Companies like Immune-Onc Therapeutics

In the same sector, and raised in the last eighteen months.

[**Matchpoint Therapeutics** $220M · Oct 2026](https://millionrounds.com/company/matchpoint-therapeutics)[**Rx Bandz** Oct 2026](https://millionrounds.com/company/rx-bandz)[**Hera Biotech** $1.8M · Sept 2026](https://millionrounds.com/company/hera-biotech)[**GevRx Nutraceuticals** $300K · Sept 2026](https://millionrounds.com/company/gevrx-nutraceuticals)[**RegCell** $81M · Sept 2026](https://millionrounds.com/company/regcell)[**ClearSight Therapeutics** $307K · Sept 2026](https://millionrounds.com/company/clearsight-therapeutics)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app